These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 15056653)

  • 1. Solution structure and backbone dynamics of the non-receptor protein-tyrosine kinase-6 Src homology 2 domain.
    Hong E; Shin J; Kim HI; Lee ST; Lee W
    J Biol Chem; 2004 Jul; 279(28):29700-8. PubMed ID: 15056653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An intramolecular interaction between SH2-kinase linker and kinase domain is essential for the catalytic activity of protein-tyrosine kinase-6.
    Kim HIe; Lee ST
    J Biol Chem; 2005 Aug; 280(32):28973-80. PubMed ID: 15961400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural basis of the auto-inhibition mechanism of nonreceptor tyrosine kinase PTK6.
    Ko S; Ahn KE; Lee YM; Ahn HC; Lee W
    Biochem Biophys Res Commun; 2009 Jun; 384(2):236-42. PubMed ID: 19401189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The solution structure of Abl SH3, and its relationship to SH2 in the SH(32) construct.
    Gosser YQ; Zheng J; Overduin M; Mayer BJ; Cowburn D
    Structure; 1995 Oct; 3(10):1075-86. PubMed ID: 8590002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A specific intermolecular association between the regulatory domains of a Tec family kinase.
    Brazin KN; Fulton DB; Andreotti AH
    J Mol Biol; 2000 Sep; 302(3):607-23. PubMed ID: 10986122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural insight into the binding diversity between the Tyr-phosphorylated human ephrinBs and Nck2 SH2 domain.
    Ran X; Song J
    J Biol Chem; 2005 May; 280(19):19205-12. PubMed ID: 15764601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular dissection of the interaction between the SH3 domain and the SH2-Kinase Linker region in PTK6.
    Kim HIe; Jung J; Lee ES; Kim YC; Lee W; Lee ST
    Biochem Biophys Res Commun; 2007 Nov; 362(4):829-34. PubMed ID: 17822667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purification and spectroscopic characterization of the human protein tyrosine kinase-6 SH3 domain.
    Koo BK; Kim MH; Lee ST; Lee W
    J Biochem Mol Biol; 2002 May; 35(3):343-7. PubMed ID: 12297019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solution structure of the C-terminal SH2 domain of the p85 alpha regulatory subunit of phosphoinositide 3-kinase.
    Siegal G; Davis B; Kristensen SM; Sankar A; Linacre J; Stein RC; Panayotou G; Waterfield MD; Driscoll PC
    J Mol Biol; 1998 Feb; 276(2):461-78. PubMed ID: 9512716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystal structure of the kinase domain of human protein tyrosine kinase 6 (PTK6) at 2.33 Å resolution.
    Thakur MK; Kumar A; Birudukota S; Swaminathan S; Tyagi R; Gosu R
    Biochem Biophys Res Commun; 2016 Sep; 478(2):637-42. PubMed ID: 27480927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The SH2 domain from the tyrosine kinase Fyn in complex with a phosphotyrosyl peptide reveals insights into domain stability and binding specificity.
    Mulhern TD; Shaw GL; Morton CJ; Day AJ; Campbell ID
    Structure; 1997 Oct; 5(10):1313-23. PubMed ID: 9351806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular details of Itk activation by prolyl isomerization and phospholigand binding: the NMR structure of the Itk SH2 domain bound to a phosphopeptide.
    Pletneva EV; Sundd M; Fulton DB; Andreotti AH
    J Mol Biol; 2006 Mar; 357(2):550-61. PubMed ID: 16436281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proline isomerization preorganizes the Itk SH2 domain for binding to the Itk SH3 domain.
    Severin A; Joseph RE; Boyken S; Fulton DB; Andreotti AH
    J Mol Biol; 2009 Apr; 387(3):726-43. PubMed ID: 19361414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crystal structure and NMR studies of the apo SH2 domains of ZAP-70: two bikes rather than a tandem.
    Folmer RH; Geschwindner S; Xue Y
    Biochemistry; 2002 Dec; 41(48):14176-84. PubMed ID: 12450381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solution structure of the human pp60c-src SH2 domain complexed with a phosphorylated tyrosine pentapeptide.
    Xu RX; Word JM; Davis DG; Rink MJ; Willard DH; Gampe RT
    Biochemistry; 1995 Feb; 34(7):2107-21. PubMed ID: 7532003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SH2 domain-mediated interaction of inhibitory protein tyrosine kinase Csk with protein tyrosine phosphatase-HSCF.
    Wang B; Lemay S; Tsai S; Veillette A
    Mol Cell Biol; 2001 Feb; 21(4):1077-88. PubMed ID: 11158295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel mechanism of regulation of the non-receptor protein tyrosine kinase Csk: insights from NMR mapping studies and site-directed mutagenesis.
    Shekhtman A; Ghose R; Wang D; Cole PA; Cowburn D
    J Mol Biol; 2001 Nov; 314(1):129-38. PubMed ID: 11724538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The three-dimensional solution structure of the SH2 domain from p55blk kinase.
    Metzler WJ; Leiting B; Pryor K; Mueller L; Farmer BT
    Biochemistry; 1996 May; 35(20):6201-11. PubMed ID: 8639560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solution structure of the C-terminal SH2 domain of the human tyrosine kinase Syk complexed with a phosphotyrosine pentapeptide.
    Narula SS; Yuan RW; Adams SE; Green OM; Green J; Philips TB; Zydowsky LD; Botfield MC; Hatada M; Laird ER
    Structure; 1995 Oct; 3(10):1061-73. PubMed ID: 8590001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Solution structure and phosphopeptide binding of the SH2 domain from the human Bruton's tyrosine kinase.
    Huang KC; Cheng HT; Pai MT; Tzeng SR; Cheng JW
    J Biomol NMR; 2006 Sep; 36(1):73-8. PubMed ID: 16969585
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.